Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Octanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.90 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.90 |
| ▸ | PPARG | P37231 | 7/20 | 0.90 |
| ▸ | PPARD | Q03181 | 7/20 | 0.90 |
| ▸ | PPARA | Q07869 | 7/20 | 0.90 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.90 |
| ▸ | TSHR | P16473 | 4/20 | 0.90 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.90 |
| ▸ | FABP4 | P15090 | 3/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.90 |
| ▸ | TLR2 | O60603 | 2/20 | 0.90 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.90 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.90 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.90 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.90 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.90 |
| ▸ | MEN1 | O00255 | 1/20 | 0.90 |
| ▸ | PDE4A | P27815 | 1/20 | 0.90 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL8579196 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL60794 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL1477647 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL1235050 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL585535 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL502433 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL6253364 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptanoate SCHEMBL5078565 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptanoate SCHEMBL385003 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL386211 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114728917-A | Oxamide derivative, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-105263901-B | α substituted glycyl amine derivatives | 橘生药品工业株式会社 | 2017-06-23 | — | — | CN | disclosed |
| US-20160115119-A1 | alpha-SUBSTITUTED GLYCINAMIDE DERIVATIVE | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2016-04-28 | — | — | US | disclosed |
| US-20080269238-A1 | Thiazolopyrimidine Derivative | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160115119-A1 | alpha-SUBSTITUTED GLYCINAMIDE DERIVATIVE | TRPM8, GRM8, GRIN2A | ESR1 1649/4885GPR84 220/4885PPARG 2257/4885 |
| US-20080269238-A1 | Thiazolopyrimidine Derivative | FGFR3, FGFR1, ERBB3 | ESR1 1013/4885GPR84 472/4885PPARG 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.